Great news for diabetes research @novonordisk has officially opened its new research centre (NNRCO) in collaboration with @UniofOxford with @GregClarkMP and @aahlers#diabetes
Together with @UniofOxford, we have officially opened our Research Centre Oxford! Hear our Chief Science Officer Mads Krogsgaard Thomsen explain what this means for the future treatment of #type2diabetes👇
Good day for diabetes research: The Danish Minister for Higher Education and Science @aahlers together with Parliamentary Under-Secretary of State, DHSC @jamesosh, Mads Krogsgaard Thomsen, Novo Nordisk and Sir John Bell open Novo Nordisk Research Centre Oxford (NNRCO) #diabetes
We’re ready to rumble and research with @UniofOxford! Thanks for helping us inaugurate our new Oxford Research Center where we're aiming to discover new therapeutic opportunities for the treatment of #type2diabetes
Watch what experts across the NHS have to say about future technology in healthcare. Do you work in healthcare? Submit your evidence here:
https://t.co/4TMH4U4TK7
and help prepare the #nhs#workforce for the #digital future.
https://t.co/eNGaYjlOM3
#TopolReview
Help prepare the NHS for a digital future https://t.co/Ql9Q8o6TTj @NHS_HealthEdEng wants to hear from people with experience of introducing or developing tech in health and care, especially with a perspective on the implications for the workforce and healthcare education
Immunocore is so proud of our employee Alex Powlesland -the UK's most prolific inventor - Read about his achievements in an @Oxfordtimes article here https://t.co/qLZlkqmt8w
@OBN_UK has announced their first BioTuesday event of 2018 which is taking place on the 20th February at the Saïd Business School in Oxford. https://t.co/PN7AjygAS1 #OBN_UK#BioTuesday#LifeSciences
Don't Forget - Event next Wed! Building #marketaccess into your #nhs product offering. Still places available, register now! https://t.co/tvJ4iLsS5b
@CamSciencePark @LancasterHammon
Digital #Pills That Talk to Your #Doctor Are Here!
"Tuesday’s green light from the @US_FDA means Japan’s Otsuka Pharmaceutical Co. can implant a tiny chip containing minerals like silicon, magnesium and copper inside tablets of Abilify"
#DigitalHealth
https://t.co/4puF4MRdVM